Business Description
Valneva SE is a French biotech company founded in 1998 that focuses entirely on developing and selling vaccines for infectious diseases that currently lack adequate prevention options. The company already markets three approved vaccines ? one against Japanese encephalitis, one against cholera and traveler's diarrhea, and one against chikungunya ? while advancing a broad pipeline of candidates targeting diseases such as Lyme disease, Zika, shigellosis, and others. Valneva sells its products across North America, Europe, and international markets.
